Controlled Trial of Worksite Health Education Through Face-to-face Counseling Vs. E-mail on Drinking Behavior Modification
Overview
Affiliations
This study examined the effectiveness of a traditional face-to-face health education and e-mail health education on alcohol usage among male workers in comparison with a control group. Male workers at a manufacturing plant (N=36) who had abnormal serum gamma-GTP were stratified by age and job types, then randomized into three groups: face-to-face education, e-mail education, and the control. The subjects were assessed on their knowledge about and attitude towards drinking, reported alcohol consumption, and serum gamma-GTP before the start of education and 2 months later after comparison of the education. Paired t-test and repeated ANOVA were conducted to test the significance of changes pre and post the intervention and across groups. In the face-to-face group, knowledge (p=0.001), attitude (p=0.026), alcohol consumption (p=0.003) and serum gamma-GTP showed significant improvement. In the e-mail group, only alcohol consumption showed marginal improvement (p=0.077). In the control group, no variables remarkably changed. These results indicate that the face-to-face health education was more effective than the e-mail program. We discuss why the face-to-face approach was superior to the e-mail approach in this study by referring to self-monitoring, goal setting processes and timely feedback. We concluded that further studies are warranted to identify the effect of health education using e-mails and other network tools in consideration of the above three factors.
Sundstrom C, Ivanova E, Lindner P, Johansson M, Kraepelien M Trials. 2024; 25(1):136.
PMID: 38383426 PMC: 10880249. DOI: 10.1186/s13063-024-07981-6.
What do we know about alcohol internet interventions aimed at employees?-A scoping review.
Sundstrom C, Forsstrom D, Berman A, Khadjesari Z, Sundqvist K Front Public Health. 2023; 11:929782.
PMID: 36778564 PMC: 9909699. DOI: 10.3389/fpubh.2023.929782.
Hamamura T, Suganuma S, Takano A, Matsumoto T, Shimoyama H Addict Behav Rep. 2022; 15:100400.
PMID: 35005191 PMC: 8717418. DOI: 10.1016/j.abrep.2021.100400.
Kuwabara Y, Kinjo A, Fujii M, Minobe R, Maesato H, Higuchi S Yonago Acta Med. 2021; 64(4):330-338.
PMID: 34840512 PMC: 8612880. DOI: 10.33160/yam.2021.11.002.
Younes N, Claude L, Paoletti X Front Psychiatry. 2021; 12:644980.
PMID: 34393841 PMC: 8360265. DOI: 10.3389/fpsyt.2021.644980.